Genmab A/S (GMAB) PT Lowered to $40 at Guggenheim
Tweet Send to a Friend
(Updated - February 23, 2026 6:28 AM EST)
Guggenheim analyst Michael Schmidt lowered the price target on Genmab A/S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Michael Schmidt lowered the price target on Genmab A/S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
